Thermo Fisher Scientific stock at USD 675.00 on September 25, 2026
Published on 09/28/2026 at 08:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Thermo Fisher Scientific Inc. stock last traded at USD 675.00 on the NYSE at 20:00 UTC on September 25, 2026, down 0.50 percent from the previous close. The reference session was the latest evidenced trading session ahead of the next regular session.
Recent product launch
On September 23, 2026, Thermo Fisher Scientific announced the Gibco CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed media for CHO-K1 cell culture. The company said the panel is available in liquid and dry powder formats for process development, scale-up and manufacturing. Thermo Fisher’s investor-relations release said select combinations in a 14-day fed-batch study showed up to 73.00 percent higher titer and up to 202.00 percent higher peak viable cell density than the benchmark products tested.
Precure partnership
Separately, Mayo Clinic said in a September 15, 2026 release that it launched Precure, LLC with Thermo Fisher Scientific as a founding partner. Mayo Clinic is the majority owner, while Thermo Fisher joined as a minority owner. The venture is intended to integrate proteomic, genomic and longitudinal clinical data, including molecular data from one million biospecimens. Mayo Clinic’s release said the initiative is designed to support research into early biological signals of disease, diagnostics and therapeutics.
